Evidence check: Insulin in the context of menopause

The relationship between insulin and menopause is multifaceted. Declining estrogen levels can reduce insulin sensitivity, increasing the risk of insulin resistance and type 2 diabetes. Concurrent changes in body composition (increased visceral fat) and lifestyle factors may further exacerbate this. The provided context lacks specific studies or biomarker data on this topic, so the evidence grade is unclear. Fasting insulin or HOMA-IR can offer clues but are not diagnostic alone. A comprehensive assessment including hormone panels, glucose metabolism, and lifestyle is recommended. MyBody-X tests do not provide clinically validated insights for this specific interaction.